Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer

Bibliographic Details
Main Authors:	Ali, H R, Dawson, S-J, Blows, F M, Provenzano, E, Pharoah, P D, Caldas, C
Format:	Online
Language:	English
Published:	Nature Publishing Group 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365239/

Similar Items

Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer
by: Wishart, Gordon C, et al.
Published: (2014)

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
by: Ali, H Raza, et al.
Published: (2011)

Ki-67 is a prognostic marker for hormone receptor positive tumors
by: Pérez-López, M. E., et al.
Published: (2016)

What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?
by: Xie, Shang, et al.
Published: (2016)

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.
by: Railo, M., et al.
Published: (1993)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
by: Wang, Wei, et al.
Published: (2016)

Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in Libya
by: Ermiah, Eramah, et al.
Published: (2012)

Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in Libya
by: Eramah Ermiah, Abdelbaset Buhmeida, Fathi Abdalla, Ben Romdhane Khaled, Nada Salem, Seppo Pyrhönen, Yrjö Collan
Published: (2012-01-01)

Ki67 expression in breast cancer: Correlation with prognostic markers and clinicopathological parameters in Saudi patients
by: Elkablawy, Mohamed A., et al.
Published: (2016)

Prognostic Value of Ki-67 in Breast Cancer Patients with Positive Axillary Lymph Nodes: A Retrospective Cohort Study
by: Li, Feng-yan, et al.
Published: (2014)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
by: Rossi, L, et al.
Published: (2015)

Roles of Ki67 in Breast Cancer - Important for Management?
by: Yip, C.H., et al.
Published: (2016)

Ki-67 biomarker in breast cancer of Indian women
by: Patil, Amit V., et al.
Published: (2011)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
by: Chung, Yul Ri, et al.
Published: (2016)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
by: Fasanella, S, et al.
Published: (2011)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
by: Yuan, Jing Ping, et al.
Published: (2015)

Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
by: Puri, Vandana, et al.
Published: (2011)

The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma
by: Jiang, You-Hua, et al.
Published: (2012)

Partitioning of Bronchopulmonary Carcinoids in Two Different Prognostic Categories by Ki-67 Score
by: Grimaldi, Franco, et al.
Published: (2011)

A Machine Learning Approach for the Association of ki-67 Scoring with Prognostic Factors
by: E. Dirican, et al.
Published: (2018-01-01)

Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
by: Schönherr, Alexandra, et al.
Published: (2004)

Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma
by: Jeong, Tae-Dong, et al.
Published: (2016)

Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
by: Nishimura, Reiki, et al.
Published: (2011)

Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays
by: Blows, Fiona M., et al.
Published: (2016)

Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumor
by: Bologna-Molina, Ronell, et al.
Published: (2013)

Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification
by: Ljudmilla A. G. Nielsen, et al.
Published: (2018-06-01)

Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
by: Böger, Christine, et al.
Published: (2015)

Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network
by: Klapper, Wolfram, et al.
Published: (2009)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
by: Khan, M S, et al.
Published: (2013)

Ki-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is considered
by: Tabata, Kazuhiro, et al.
Published: (2014)

Diagnostic and prognostic importance of Ki-67, MMP-9 and collagen iv immunohistochemical markers in bladder tumors
by: V P Avdoshin, et al.
Published: (2011-12-01)

Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index
by: Sasagu Kurozumi, et al.
Published: (2017-05-01)

A consensus prognostic gene expression classifier for ER positive breast cancer
by: Teschendorff, Andrew E, et al.
Published: (2006)

Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer
by: Aleskandarany, Mohammed A., et al.
Published: (2016)

Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
by: Bouzubar, N., et al.
Published: (1989)

Assessment Of Proliferation Rate In Breast Cancer By Ki-67 Labeling Index
by: Hussin Khan, Ibrahim
Published: (2017)

Semi-automated evaluation of Ki-67 index in invasive ductal carcinoma of the breast
by: SUCIU, CRISTIAN, et al.
Published: (2014)

New Insight into Ki67 Expression at the Invasive Front in Breast Cancer
by: Gong, Peng, et al.
Published: (2013)

Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
by: Kim, Kwan Il, et al.
Published: (2014)

A novel model for Ki67 assessment in breast cancer
by: Romero, Quinci, et al.
Published: (2014)